Matches in Nanopublications for { ?s ?p "[ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP935949.RAYw3CS8nNU2ESiN3ngsT0rT9YFjGvXonxdKHW0-ckWR4130_assertion description "[ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935949.RAYw3CS8nNU2ESiN3ngsT0rT9YFjGvXonxdKHW0-ckWR4130_provenance.
- assertion description "[ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_assertion description "[ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509971.RAowbwg5ukgUpgPn_FfgzwLVCNk_iqrw7E_YAePq-WjHk130_provenance.
- NP509969.RALaBKckpzjvT-r5j5NS1ryzk2f7z_WmHFYb8HM7FLZm0130_assertion description "[ELAC2 and RNASEL SNP analysis may prove useful in determining which patients are at risk for developing clinically significant prostate carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509969.RALaBKckpzjvT-r5j5NS1ryzk2f7z_WmHFYb8HM7FLZm0130_provenance.